Segall Bryant & Hamill LLC acquired a new position in shares of InMode Ltd. (NASDAQ:INMD – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 76,267 shares of the healthcare company’s stock, valued at approximately $1,274,000. Segall Bryant & Hamill LLC owned about 0.11% of InMode at the end of the most recent reporting period.
A number of other institutional investors have also recently bought and sold shares of INMD. Fox Run Management L.L.C. bought a new position in shares of InMode during the fourth quarter worth $660,000. KLP Kapitalforvaltning AS bought a new position in InMode during the fourth quarter worth about $745,000. American Century Companies Inc. acquired a new position in InMode in the fourth quarter valued at about $299,000. Teacher Retirement System of Texas bought a new stake in shares of InMode in the fourth quarter worth about $306,000. Finally, Intech Investment Management LLC increased its holdings in shares of InMode by 36.3% in the fourth quarter. Intech Investment Management LLC now owns 42,300 shares of the healthcare company’s stock worth $706,000 after acquiring an additional 11,260 shares in the last quarter. Institutional investors and hedge funds own 68.04% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities analysts recently issued reports on the company. Barclays boosted their price objective on InMode from $26.00 to $29.00 and gave the company an “overweight” rating in a research report on Wednesday, February 5th. Needham & Company LLC reiterated a “hold” rating on shares of InMode in a report on Tuesday, February 4th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $22.25.
InMode Stock Performance
NASDAQ INMD opened at $17.70 on Friday. InMode Ltd. has a 52 week low of $14.87 and a 52 week high of $21.76. The stock’s 50 day moving average price is $18.32 and its two-hundred day moving average price is $17.77. The stock has a market capitalization of $1.23 billion, a price-to-earnings ratio of 7.53 and a beta of 2.08.
About InMode
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.
Featured Stories
- Five stocks we like better than InMode
- Trading Stocks: RSI and Why it’s Useful
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- Stock Market Upgrades: What Are They?
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- What is Forex and How Does it Work?
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter.